| __timestamp | Eli Lilly and Company | Pfizer Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 4733600000 | 8393000000 |
| Thursday, January 1, 2015 | 4796400000 | 7690000000 |
| Friday, January 1, 2016 | 5243900000 | 7872000000 |
| Sunday, January 1, 2017 | 5281800000 | 7657000000 |
| Monday, January 1, 2018 | 5051200000 | 8006000000 |
| Tuesday, January 1, 2019 | 5595000000 | 8650000000 |
| Wednesday, January 1, 2020 | 6085700000 | 9405000000 |
| Friday, January 1, 2021 | 7025900000 | 13829000000 |
| Saturday, January 1, 2022 | 7190800000 | 11428000000 |
| Sunday, January 1, 2023 | 9313400000 | 10679000000 |
| Monday, January 1, 2024 | 14271000000 | 10930000000 |
In pursuit of knowledge
In the competitive world of pharmaceuticals, innovation is key. Over the past decade, Eli Lilly and Pfizer have been at the forefront of research and development (R&D) spending. From 2014 to 2023, Pfizer consistently outpaced Eli Lilly in R&D investment, with an average annual expenditure of approximately $9.4 billion, compared to Eli Lilly's $6 billion. However, Eli Lilly has shown a remarkable growth trajectory, increasing its R&D spending by nearly 97% from 2014 to 2023. In 2023, Eli Lilly's R&D expenses surged to $9.3 billion, closing the gap with Pfizer, which spent $10.7 billion. This trend highlights Eli Lilly's aggressive push towards innovation, potentially reshaping the pharmaceutical landscape. As these giants continue to invest heavily in R&D, the future of medicine looks promising, with new breakthroughs on the horizon.
Analyzing R&D Budgets: Eli Lilly and Company vs Zoetis Inc.
Research and Development Investment: Eli Lilly and Company vs argenx SE
Research and Development: Comparing Key Metrics for Eli Lilly and Company and BeiGene, Ltd.
R&D Insights: How Eli Lilly and Company and Verona Pharma plc Allocate Funds
Research and Development: Comparing Key Metrics for Eli Lilly and Company and Amicus Therapeutics, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Eli Lilly and Company and MiMedx Group, Inc.
Pfizer Inc. vs Jazz Pharmaceuticals plc: Strategic Focus on R&D Spending
Who Prioritizes Innovation? R&D Spending Compared for Pfizer Inc. and Grifols, S.A.
R&D Insights: How Pfizer Inc. and TG Therapeutics, Inc. Allocate Funds
Who Prioritizes Innovation? R&D Spending Compared for Pfizer Inc. and Protagonist Therapeutics, Inc.
Pfizer Inc. or Amphastar Pharmaceuticals, Inc.: Who Invests More in Innovation?
R&D Insights: How Pfizer Inc. and Novavax, Inc. Allocate Funds